Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1966-7-30
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0036-472X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20-31
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4286748-Adult,
pubmed-meshheading:4286748-Angiotensin II,
pubmed-meshheading:4286748-Blood Pressure,
pubmed-meshheading:4286748-Clinical Trials as Topic,
pubmed-meshheading:4286748-Humans,
pubmed-meshheading:4286748-Hypertension,
pubmed-meshheading:4286748-Middle Aged,
pubmed-meshheading:4286748-Norepinephrine
|
pubmed:articleTitle |
[Clinical studies on the etiology of essential hypertension. Pressor response to noradrenaline].
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|